DiscoverWavesDecks

BIOCAD Announced the Registration of Anti-IL17 Netakimab in Russia

BIOCAD Announced the Registration of Anti-IL17 Netakimab in Russia

Published in

Words

0

Reading

0 min

Listen

Play

2019-05-15 09:46

Moscow-based BIOCAD announced the registration of netakimab (Efleira®, BCD-085), a new pharmaceutical drug for plaque psoriasis treatment. New medication will hit the market in June 2019.

https://genexi.io/news/BIOCAD-Announced-the-Registration-of-Anti-IL17-Netakimab-in-Russia-en

2019-05-15 09:46

This post was published via steemit. Ecency is not the originator or editor of this content and displays it for discovery purposes only.

$ 0.000

0